Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies

Investigative Radiology

Volumn 42, Issue 3, 2007, Pages 172-179

  Bisdas, Sotirios ^a,d   Baghi, Mehran ^a   Smolarz, Agnieszka ^a   Pihno, Nicole Chambron ^a   Lehnert, Thomas ^a   Knecht, Rainald ^a   Mack, Martin G ^a   Vogl, Thomas J ^a   Tuerkay, Sehib ^b   Koh, Tong San ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GE HEALTHCARE   (Germany)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d NONE   (Germany)

Author keywords

Blood flow; Blood volume; Mean transit time; Oropharynx cancer; Perfusion CT; Permeability

Indexed keywords

IMERON; IODINATED CONTRAST MEDIUM; NONIONIC CONTRAST MEDIUM; UNCLASSIFIED DRUG;

AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD VOLUME; CANCER DIAGNOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEASIBILITY STUDY; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECURRENT CANCER; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 33846938307     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000252496.74242.0b     Document Type: Article

References (22)

1. Yom SS, Machtay M, Biel MA, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005;28:385-392.
2. Glazer HS, Niemeyer JH, Balfe DM, et al. Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. Radiology. 1986;160:349-354.
3. Lee TY. Functional CT: physiological models. Trends Biotechnol. 2002;20(Suppl):S3-S10.
4. Wintermark M, Maeder P, Thiran JP, et al. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol. 2001;11:1220-1230.
5. Eastwood JD, Lev MH, Azhari T, et al. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology. 2002;222:227-236.
6. Roberts HC, Roberts TPL, Lee TY, et al. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow and microvascular permeability: report of two cases. AJNR Am J Neuroradiol. 2002;23:828-832.
7. Hermans R, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Rad Oncol. 1999;53:105-111.
8. Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiation Oncology Biol Phys. 2003;57:1351-1356.
9. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology. 2001;220:548-553.
10. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol. 2003;76:220-231.
11. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol. 2005;26:1178-1185.
12. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr. 2003;27:687-693.
13. Goh V, Halligan S, Hugill JA, et al. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced, multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr. 2005;29:59-63.
14. Blomley MJ, Coulden R, Bufkin C, et al. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest Radiol. 1993;28(Suppl 5):S72-S77; discussion S78.
15. Brix G, Bahner ML, Hoffmann U, et al. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology. 1999;210:269-276.
16. Szolar DH, Saeed M, Flueckiger F, et al. Effects of iopromide on vasoactive peptides and allergy-mediated substances in healthy volunteers. Invest Radiol. 1995;30:144-149.
17. Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol. 2006;27:101-106.
18. Wheeler RH, Ziesmann HE, Medvec BR, et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res. 1986;46:4200-4204.
19. Pollard RE, Garcia TC, Stieger SM, et al. Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography. Invest Radiol. 2004;39:340-349.
20. Lurie DM, Seguin B, Schneider PD, et al. Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arised canine head and neck tumors. Invest Radiol. 2006;41:415-421.
21. Bourrinet P, Bengele HH, Bonnemain B, et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol. 2006;41:313-324.
22. Dugdale PE, Miles KA, Bunce I, et al. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr. 1999;23:540-547.